The role of molecuclar imaging in modern drug development

Cunha, Lídia Alexandra dos Santos

Publication

The role of molecuclar imaging in modern drug development

2013Report

dc.contributor.author	Cunha, Lídia Alexandra dos Santos
dc.date.accessioned	2024-05-21T14:35:44Z
dc.date.available	2024-05-21T14:35:44Z
dc.date.issued	2013
dc.description	Documento Técnico submetido para suporte à Candidatura ao Título de Especialista no Grupo 7 – Saúde e Protecção Social / Área de Estudo 72 – Saúde / Área de Educação e Formação 725 – Tecnologias de Diagnóstico e Terapêutica / Medicina Nuclear	pt_PT
dc.description.abstract	Drug development represents a highly complex, inefficient and costly process. Over the last decade, the widespread use of nuclear imaging, due to its functional and molecular nature, has proven to be determinant in improving the efficiency on selecting the candidate drugs that should be abandoned or move forward to clinical. This reflects not only into the development of safer and effective drugs, but also the shortening of time-to-market. The modern concept and future trends concerning molecular imaging is assumedly hybrid or multimodality imaging, including combinations between high sensitivity and functional (molecular) modalities with high spatial resolution and morphological techniques	pt_PT
dc.description.version	N/A	pt_PT
dc.identifier.uri	http://hdl.handle.net/10400.22/25541
dc.language.iso	eng	pt_PT
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/4.0/	pt_PT
dc.subject	Drug development	pt_PT
dc.subject	Molecular imaging	pt_PT
dc.subject	Nuclear imaging	pt_PT
dc.subject	PET/SPECT biomarkers	pt_PT
dc.subject	Radiochemistry	pt_PT
dc.title	The role of molecuclar imaging in modern drug development	pt_PT
dc.type	report
dspace.entity.type	Publication
rcaap.rights	closedAccess	pt_PT
rcaap.type	report	pt_PT